A Study to Evaluate CBP-201, Rademikibart, in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps
Public ClinicalTrials.gov record NCT04783389. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate CBP-201 in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the effect of CBP-201, rademikibart, in adult patients with Chronic Rhinosinusitis with Nasal Polyps (CRSwNP).
Study identification
- NCT ID
- NCT04783389
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 16, 2021 (Actual)
- Primary completion
- Apr 15, 2022 (Actual)
- Completion
- Jun 10, 2022 (Actual)
- Last update posted
- Oct 17, 2023
2021 – 2022
United States locations
- U.S. sites
- 32
- U.S. states
- 19
- U.S. cities
- 29
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Connect Investigative Site 130 | Birmingham | Alabama | 35205 | — |
| Connect Investigative Site 124 | Bakersfield | California | 93301 | — |
| Connect Investigative Site 125 | La Mesa | California | 91942 | — |
| Connect Investigative Site 134 | Los Angeles | California | 90048 | — |
| Connect Investigative Site 128 | Temecula | California | 92592 | — |
| Connect Investigative Site 119 | Torrance | California | 90503 | — |
| Connect Investigative Site 114 | Miami | Florida | 33135 | — |
| Connect Investigative Site 109 | Miami | Florida | 33155 | — |
| Connect Investigative Site 116 | Tampa | Florida | 33613 | — |
| Connect Investigative Site 111 | Chicago | Illinois | 60637 | — |
| Connect Investigative Site 126 | Chicago | Illinois | 60657 | — |
| Connect Investigative Site 132 | Louisville | Kentucky | 40205 | — |
| Connect Investigative Site 110 | White Marsh | Maryland | 21162 | — |
| Connect Investigative Site 121 | Ann Arbor | Michigan | 48109-0360 | — |
| Connect Investigative Site 127 | St Louis | Missouri | 63141 | — |
| Connect Investigative Site 102 | Princeton | New Jersey | 08540 | — |
| Connect Investigative Site 105 | Rochester | New York | 14618 | — |
| Connect Investigative Site 113 | The Bronx | New York | 10461 | — |
| Connect Investigative Site 117 | Winston-Salem | North Carolina | 27103 | — |
| Connect Investigative Site 123 | Cincinnati | Ohio | 45229 | — |
| Connect Investigative Site 133 | Columbus | Ohio | 43235 | — |
| Connect Investigative Site 112 | Tulsa | Oklahoma | 74136 | — |
| Connect Investigative Site 122 | Tulsa | Oklahoma | 74137 | — |
| Connect Investigative Site 108 | Charleston | South Carolina | 29425 | — |
| Connect Investigative Site 107 | Memphis | Tennessee | 38119 | — |
| Connect Investigative Site 106 | Austin | Texas | 75759 | — |
| Connect Investigative Site 104 | Dallas | Texas | 75231 | — |
| Connect Investigative Site 120 | Houston | Texas | 77074 | — |
| Connect Investigative Site 101 | Sherman | Texas | 75092 | — |
| Connect Investigative Site 129 | St. George | Utah | 84790 | — |
| Connect Investigative Site 118 | Norfolk | Virginia | 23507 | — |
| Connect Investigative Site 115 | Bellingham | Washington | 98225 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04783389, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 17, 2023 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04783389 live on ClinicalTrials.gov.